{
    "title": "AstraZeneca expects demand for its vaccine to wane this year but saw revenues rise 60% in the first quarter",
    "url": "https://www.dailymail.co.uk/money/markets/article-10766745/AstraZeneca-set-lose-fifth-revenue-demand-Covid-19-vaccine-wanes.html",
    "date": "2022-04-29",
    "keywords": [
        "year",
        "cent",
        "revenue",
        "quarter",
        "share",
        "alexion",
        "astrazeneca",
        "growth",
        "product",
        "development",
        "investment",
        "vaccine",
        "research",
        "drug",
        "fund",
        "covid19",
        "fifth",
        "demand",
        "business",
        "period",
        "announcement",
        "continent",
        "shot",
        "market",
        "covid",
        "treatment",
        "month",
        "acquisition",
        "july",
        "company",
        "move",
        "percentage",
        "cambridge",
        "massachusetts",
        "analyst",
        "china",
        "country",
        "place",
        "account",
        "fee",
        "vaccinethe",
        "oxfordastrazeneca",
        "europe",
        "vaccineoverall",
        "impact",
        "exchange",
        "contribution",
        "portfolio",
        "covidvaccine",
        "contractsa",
        "report",
        "return",
        "surgery",
        "article",
        "use",
        "antibody",
        "firstquarter",
        "consensus",
        "pharma",
        "giant",
        "cash",
        "charge",
        "revaluation",
        "inventory",
        "time",
        "billionit",
        "staff",
        "serve",
        "moment",
        "executive",
        "soriotour",
        "catalyst",
        "collaboration",
        "access",
        "academia",
        "offering",
        "collaborate",
        "science",
        "increase",
        "profit",
        "declinethe",
        "group",
        "site",
        "investor",
        "cancer",
        "core",
        "nearer",
        "disease",
        "takeover",
        "guidance",
        "centre",
        "continue",
        "purchase",
        "price",
        "debt",
        "innovation",
        "presence",
        "revenuethe",
        "drugmaker",
        "part"
    ],
    "category": [
        "money",
        "markets"
    ]
}